Evidence-Based Medicine Guidelines
Intranasal sumatriptan for acute migraine
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intranasal Sumatriptan for Acute Migraine." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457583/all/Intranasal_sumatriptan_for_acute_migraine.
Intranasal sumatriptan for acute migraine. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/457583/all/Intranasal_sumatriptan_for_acute_migraine. Accessed October 6, 2024.
Intranasal sumatriptan for acute migraine. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/457583/all/Intranasal_sumatriptan_for_acute_migraine
Intranasal Sumatriptan for Acute Migraine [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457583/all/Intranasal_sumatriptan_for_acute_migraine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intranasal sumatriptan for acute migraine
ID - 457583
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457583/all/Intranasal_sumatriptan_for_acute_migraine
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
